Patents by Inventor Saema Ansar

Saema Ansar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8273771
    Abstract: The invention relates to the use of at least on inhibitor selected from the group consisting of raf-, protein kinase C (PKC)-, MEK1/2-, or ERK1/2-inhibitors, for the manufacturing of a medicament to be administrated from 1 up to 12 hours after initiation of an ischemic disease.
    Type: Grant
    Filed: March 25, 2008
    Date of Patent: September 25, 2012
    Assignee: Pronas Pharma AB
    Inventors: Lars Edvinsson, Saema Ansar
  • Publication number: 20100152248
    Abstract: The invention relates to the use of at least on inhibitor selected from the group consisting of raf-, protein kinase C(PKC)-, MEK1/2-, or ERK1/2-inhibitors, for the manufacturing of a medicament to be administrated from 1 up to 12 hours after initiation of an ischemic disease.
    Type: Application
    Filed: March 25, 2008
    Publication date: June 17, 2010
    Applicant: Pronas Pharma AB
    Inventors: Lars Edvinsson, Saema Ansar